title: Goserelin (Zoladex) versus danazol for endometriosis: the North American experience.
authors.affiliation: Emory University School of Medicine, Department of Gynecology and Obstetrics, Atlanta, Georgia 30322.
authors.forename: M A
authors.initials: MA
authors.lastname: Damario
authors.forename: J A
authors.initials: JA
authors.lastname: Rock
mesh_terms: D003613:Danazol / Q000009:adverse effects / Q000627:therapeutic use*; D004715:Endometriosis / Q000188:drug therapy*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D017273:Goserelin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic
chemical_list: D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone; D003613:Danazol